|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.82 CNY | -2.39% |
|
-5.29% | +19.65% |
| Capitalization | 4.63B 657M 559M 522M 489M 905M 59.23B 985M 6.08B 2.36B 27.98B 2.46B 2.41B 102B | P/E ratio 2023 |
26.3x | P/E ratio 2024 | 22.3x |
|---|---|---|---|---|---|
| Enterprise value | 3.83B 543M 462M 431M 404M 748M 48.95B 814M 5.02B 1.95B 23.13B 2.04B 1.99B 84.26B | EV / Sales 2023 |
5.07x | EV / Sales 2024 | 4.23x |
| Free-Float |
21.26% | Yield 2023 |
1.92% | Yield 2024 | 2.89% |
More valuation ratios
* Estimated data
More news
| 1 day | -2.39% | ||
| 1 week | -5.29% | ||
| Current month | -5.06% | ||
| 1 month | -10.18% | ||
| 3 months | -13.34% | ||
| 6 months | -29.22% | ||
| Current year | +19.65% |
| 1 week | 11.8 |  | 12.41 |
| 1 month | 11.8 | | 13.84 |
| Current year | 9.21 | | 18.38 |
| 1 year | 9.21 | | 18.38 |
| 3 years | 6.64 | | 18.38 |
| 5 years | 6.64 | | 18.38 |
| 10 years | 6.64 | | 18.38 |
| Manager | Title | Age | Since |
|---|---|---|---|
Lu Wei Zhang
CEO | Chief Executive Officer | 54 | 31/07/2015 |
Qing Kui Wang
DFI | Director of Finance/CFO | 46 | 30/09/2020 |
Hong Min Liu
CTO | Chief Tech/Sci/R&D Officer | 65 | 28/02/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Jian Zhong Xie
CHM | Chairman | 60 | 31/03/2009 |
Wan Min Liu
BRD | Director/Board Member | 58 | 31/08/2005 |
Lu Wei Zhang
BRD | Director/Board Member | 54 | 31/08/2005 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.39% | -5.29% | +6.69% | -3.47% | 672M | |
| +1.58% | -2.34% | +26.24% | +179.61% | 890B | |
| +1.68% | +2.28% | +40.73% | +19.50% | 498B | |
| -0.53% | -2.72% | +27.50% | +37.36% | 398B | |
| -1.27% | +1.31% | +25.26% | +4.37% | 343B | |
| +0.61% | -0.72% | +29.34% | +19.75% | 279B | |
| +0.53% | -1.32% | +19.40% | +23.98% | 252B | |
| +1.42% | -3.19% | -1.97% | -8.98% | 242B | |
| +3.43% | +5.23% | -59.14% | -30.63% | 214B | |
| +0.63% | -8.12% | +15.10% | +13.90% | 170B | |
| Average | +0.44% | -2.11% | +12.91% | +25.54% | 328.64B | |
| Weighted average by Cap. | +0.83% | -1.87% | +20.00% | +58.13% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 651M 92.3M 78.53M 73.32M 68.78M 127M 8.33B 138M 854M 332M 3.93B 346M 339M 14.33B | 726M 103M 87.57M 81.76M 76.7M 142M 9.28B 154M 953M 370M 4.39B 386M 378M 15.98B |
| Net income | 159M 22.53M 19.16M 17.89M 16.79M 31.04M 2.03B 33.79M 208M 81M 960M 84.53M 82.74M 3.5B | 174M 24.6M 20.93M 19.54M 18.33M 33.9M 2.22B 36.91M 228M 88.46M 1.05B 92.32M 90.36M 3.82B |
| Net Debt | -857M -121M -103M -96.43M -90.47M -167M -10.95B -182M -1.12B -437M -5.17B -456M -446M -18.85B | -804M -114M -96.89M -90.46M -84.87M -157M -10.27B -171M -1.05B -410M -4.85B -427M -418M -17.68B |
More financial data
* Estimated data
Employees
1,042
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/12/25 | 11.82 ¥ | -2.39% | 2,563,376 |
| 10/12/25 | 12.11 ¥ | 0.00% | 1,569,697 |
| 09/12/25 | 12.11 ¥ | -1.46% | 2,219,896 |
| 08/12/25 | 12.29 ¥ | +0.24% | 1,759,762 |
| 05/12/25 | 12.26 ¥ | +0.16% | 2,318,300 |
End-of-day quote Shenzhen S.E., December 10, 2025
More quotes
- Stock Market
- Equities
- 301277 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition